nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP19A1—breast cancer	0.21	0.68	CbGaD
Letrozole—CYP19A1—Exemestane—breast cancer	0.123	0.269	CbGbCtD
Letrozole—CYP3A4—breast cancer	0.0987	0.32	CbGaD
Letrozole—CYP19A1—Anastrozole—breast cancer	0.0933	0.204	CbGbCtD
Letrozole—CYP19A1—Raloxifene—breast cancer	0.0472	0.103	CbGbCtD
Letrozole—CYP19A1—Tamoxifen—breast cancer	0.0312	0.0681	CbGbCtD
Letrozole—CYP19A1—Paclitaxel—breast cancer	0.0243	0.053	CbGbCtD
Letrozole—CYP2A6—Tamoxifen—breast cancer	0.0197	0.0432	CbGbCtD
Letrozole—CYP3A4—Exemestane—breast cancer	0.0156	0.0341	CbGbCtD
Letrozole—CYP2A6—Fluorouracil—breast cancer	0.0146	0.0318	CbGbCtD
Letrozole—CYP3A4—Anastrozole—breast cancer	0.0118	0.0258	CbGbCtD
Letrozole—CYP3A4—Toremifene—breast cancer	0.0108	0.0236	CbGbCtD
Letrozole—CYP3A4—Fulvestrant—breast cancer	0.0101	0.022	CbGbCtD
Letrozole—CYP3A4—Thiotepa—breast cancer	0.00896	0.0196	CbGbCtD
Letrozole—CYP3A4—Ixabepilone—breast cancer	0.00819	0.0179	CbGbCtD
Letrozole—CYP3A4—Lapatinib—breast cancer	0.00789	0.0172	CbGbCtD
Letrozole—CYP3A4—Raloxifene—breast cancer	0.00598	0.0131	CbGbCtD
Letrozole—CYP19A1—corpus luteum—breast cancer	0.00596	0.609	CbGeAlD
Letrozole—CYP3A4—Vinorelbine—breast cancer	0.00437	0.00956	CbGbCtD
Letrozole—CYP3A4—Tamoxifen—breast cancer	0.00395	0.00863	CbGbCtD
Letrozole—CYP3A4—Mitoxantrone—breast cancer	0.00385	0.00842	CbGbCtD
Letrozole—CYP3A4—Paclitaxel—breast cancer	0.00307	0.00672	CbGbCtD
Letrozole—CYP3A4—Irinotecan—breast cancer	0.00303	0.00663	CbGbCtD
Letrozole—CYP3A4—Vinblastine—breast cancer	0.0027	0.00589	CbGbCtD
Letrozole—CYP3A4—Docetaxel—breast cancer	0.00222	0.00486	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—breast cancer	0.00166	0.00362	CbGbCtD
Letrozole—Bifonazole—CYP17A1—breast cancer	0.00106	0.572	CrCbGaD
Letrozole—Bifonazole—CYP19A1—breast cancer	0.000539	0.291	CrCbGaD
Letrozole—CYP2A6—adipose tissue—breast cancer	0.00053	0.0542	CbGeAlD
Letrozole—CYP19A1—endometrium—breast cancer	0.000461	0.0472	CbGeAlD
Letrozole—CYP19A1—uterus—breast cancer	0.000425	0.0434	CbGeAlD
Letrozole—CYP19A1—adipose tissue—breast cancer	0.000416	0.0425	CbGeAlD
Letrozole—CYP19A1—female reproductive system—breast cancer	0.000382	0.0391	CbGeAlD
Letrozole—CYP19A1—adrenal gland—breast cancer	0.000373	0.0381	CbGeAlD
Letrozole—CYP19A1—female gonad—breast cancer	0.000348	0.0355	CbGeAlD
Letrozole—CYP19A1—endocrine gland—breast cancer	0.000323	0.0331	CbGeAlD
Letrozole—Bifonazole—CYP3A4—breast cancer	0.000253	0.137	CrCbGaD
Letrozole—CYP19A1—lymph node—breast cancer	0.000224	0.0228	CbGeAlD
Letrozole—CYP3A4—female reproductive system—breast cancer	0.000185	0.0189	CbGeAlD
Letrozole—CYP3A4—endocrine gland—breast cancer	0.000157	0.016	CbGeAlD
Letrozole—Rash—Mitoxantrone—breast cancer	2.11e-05	0.000118	CcSEcCtD
Letrozole—Dermatitis—Mitoxantrone—breast cancer	2.11e-05	0.000118	CcSEcCtD
Letrozole—Dermatitis—Irinotecan—breast cancer	2.11e-05	0.000118	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Docetaxel—breast cancer	2.1e-05	0.000118	CcSEcCtD
Letrozole—Headache—Irinotecan—breast cancer	2.09e-05	0.000118	CcSEcCtD
Letrozole—Headache—Mitoxantrone—breast cancer	2.09e-05	0.000118	CcSEcCtD
Letrozole—Insomnia—Docetaxel—breast cancer	2.09e-05	0.000117	CcSEcCtD
Letrozole—Paraesthesia—Docetaxel—breast cancer	2.07e-05	0.000117	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—breast cancer	2.07e-05	0.000116	CcSEcCtD
Letrozole—Alopecia—Methotrexate—breast cancer	2.07e-05	0.000116	CcSEcCtD
Letrozole—Vomiting—Gemcitabine—breast cancer	2.07e-05	0.000116	CcSEcCtD
Letrozole—Dyspnoea—Docetaxel—breast cancer	2.06e-05	0.000116	CcSEcCtD
Letrozole—Somnolence—Docetaxel—breast cancer	2.05e-05	0.000115	CcSEcCtD
Letrozole—Mental disorder—Methotrexate—breast cancer	2.05e-05	0.000115	CcSEcCtD
Letrozole—Rash—Gemcitabine—breast cancer	2.05e-05	0.000115	CcSEcCtD
Letrozole—Dermatitis—Gemcitabine—breast cancer	2.05e-05	0.000115	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—breast cancer	2.05e-05	0.000115	CcSEcCtD
Letrozole—Malnutrition—Methotrexate—breast cancer	2.04e-05	0.000115	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—breast cancer	2.04e-05	0.000115	CcSEcCtD
Letrozole—Headache—Gemcitabine—breast cancer	2.04e-05	0.000115	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Capecitabine—breast cancer	2.04e-05	0.000114	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—breast cancer	2.04e-05	0.000114	CcSEcCtD
Letrozole—Flushing—Epirubicin—breast cancer	2.04e-05	0.000114	CcSEcCtD
Letrozole—Vomiting—Fluorouracil—breast cancer	2.04e-05	0.000114	CcSEcCtD
Letrozole—Dyspepsia—Docetaxel—breast cancer	2.03e-05	0.000114	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—breast cancer	2.03e-05	0.000114	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—breast cancer	2.03e-05	0.000114	CcSEcCtD
Letrozole—Insomnia—Capecitabine—breast cancer	2.02e-05	0.000114	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—breast cancer	2.02e-05	0.000113	CcSEcCtD
Letrozole—Rash—Fluorouracil—breast cancer	2.02e-05	0.000113	CcSEcCtD
Letrozole—Dermatitis—Fluorouracil—breast cancer	2.02e-05	0.000113	CcSEcCtD
Letrozole—Paraesthesia—Capecitabine—breast cancer	2.01e-05	0.000113	CcSEcCtD
Letrozole—Decreased appetite—Docetaxel—breast cancer	2.01e-05	0.000113	CcSEcCtD
Letrozole—Headache—Fluorouracil—breast cancer	2.01e-05	0.000113	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—breast cancer	2e-05	0.000113	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—breast cancer	2e-05	0.000112	CcSEcCtD
Letrozole—Dysgeusia—Methotrexate—breast cancer	2e-05	0.000112	CcSEcCtD
Letrozole—Gastrointestinal disorder—Docetaxel—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Dyspnoea—Capecitabine—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Fatigue—Docetaxel—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Nausea—Mitoxantrone—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Nausea—Irinotecan—breast cancer	1.99e-05	0.000112	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—breast cancer	1.98e-05	0.000111	CcSEcCtD
Letrozole—Pain—Docetaxel—breast cancer	1.98e-05	0.000111	CcSEcCtD
Letrozole—Constipation—Docetaxel—breast cancer	1.98e-05	0.000111	CcSEcCtD
Letrozole—Back pain—Methotrexate—breast cancer	1.97e-05	0.000111	CcSEcCtD
Letrozole—Dyspepsia—Capecitabine—breast cancer	1.97e-05	0.000111	CcSEcCtD
Letrozole—Asthenia—Paclitaxel—breast cancer	1.96e-05	0.00011	CcSEcCtD
Letrozole—Decreased appetite—Capecitabine—breast cancer	1.94e-05	0.000109	CcSEcCtD
Letrozole—Alopecia—Epirubicin—breast cancer	1.94e-05	0.000109	CcSEcCtD
Letrozole—Nausea—Gemcitabine—breast cancer	1.93e-05	0.000109	CcSEcCtD
Letrozole—Gastrointestinal disorder—Capecitabine—breast cancer	1.93e-05	0.000108	CcSEcCtD
Letrozole—Fatigue—Capecitabine—breast cancer	1.93e-05	0.000108	CcSEcCtD
Letrozole—Pruritus—Paclitaxel—breast cancer	1.93e-05	0.000108	CcSEcCtD
Letrozole—Vision blurred—Methotrexate—breast cancer	1.92e-05	0.000108	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—breast cancer	1.92e-05	0.000108	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—breast cancer	1.92e-05	0.000108	CcSEcCtD
Letrozole—Pain—Capecitabine—breast cancer	1.91e-05	0.000107	CcSEcCtD
Letrozole—Constipation—Capecitabine—breast cancer	1.91e-05	0.000107	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—breast cancer	1.91e-05	0.000107	CcSEcCtD
Letrozole—CYP19A1—Metabolism—PPARGC1B—breast cancer	1.9e-05	0.000434	CbGpPWpGaD
Letrozole—Feeling abnormal—Docetaxel—breast cancer	1.9e-05	0.000107	CcSEcCtD
Letrozole—Nausea—Fluorouracil—breast cancer	1.9e-05	0.000107	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—breast cancer	1.9e-05	0.000107	CcSEcCtD
Letrozole—Ill-defined disorder—Methotrexate—breast cancer	1.89e-05	0.000106	CcSEcCtD
Letrozole—Gastrointestinal pain—Docetaxel—breast cancer	1.89e-05	0.000106	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—breast cancer	1.88e-05	0.000106	CcSEcCtD
Letrozole—Flushing—Doxorubicin—breast cancer	1.88e-05	0.000106	CcSEcCtD
Letrozole—Tension—Epirubicin—breast cancer	1.87e-05	0.000105	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—breast cancer	1.87e-05	0.000105	CcSEcCtD
Letrozole—Diarrhoea—Paclitaxel—breast cancer	1.87e-05	0.000105	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—NCOR1—breast cancer	1.85e-05	0.000422	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—breast cancer	1.85e-05	0.000422	CbGpPWpGaD
Letrozole—Nervousness—Epirubicin—breast cancer	1.85e-05	0.000104	CcSEcCtD
Letrozole—Back pain—Epirubicin—breast cancer	1.85e-05	0.000104	CcSEcCtD
Letrozole—Feeling abnormal—Capecitabine—breast cancer	1.84e-05	0.000104	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—breast cancer	1.84e-05	0.000103	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HADHB—breast cancer	1.84e-05	0.000419	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPI—breast cancer	1.84e-05	0.000419	CbGpPWpGaD
Letrozole—Malaise—Methotrexate—breast cancer	1.84e-05	0.000103	CcSEcCtD
Letrozole—Vertigo—Methotrexate—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Gastrointestinal pain—Capecitabine—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Abdominal pain—Docetaxel—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Body temperature increased—Docetaxel—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Leukopenia—Methotrexate—breast cancer	1.83e-05	0.000103	CcSEcCtD
Letrozole—Dizziness—Paclitaxel—breast cancer	1.8e-05	0.000101	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—breast cancer	1.8e-05	0.000101	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTA4—breast cancer	1.8e-05	0.00041	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CA9—breast cancer	1.8e-05	0.00041	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—TP53—breast cancer	1.8e-05	0.00041	CbGpPWpGaD
Letrozole—Alopecia—Doxorubicin—breast cancer	1.79e-05	0.000101	CcSEcCtD
Letrozole—CYP2A6—NRF2 pathway—TGFB1—breast cancer	1.79e-05	0.000407	CbGpPWpGaD
Letrozole—Cough—Methotrexate—breast cancer	1.78e-05	0.0001	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—breast cancer	1.78e-05	9.99e-05	CcSEcCtD
Letrozole—Urticaria—Capecitabine—breast cancer	1.78e-05	9.98e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—GPX1—breast cancer	1.78e-05	0.000404	CbGpPWpGaD
Letrozole—Ill-defined disorder—Epirubicin—breast cancer	1.77e-05	9.95e-05	CcSEcCtD
Letrozole—Abdominal pain—Capecitabine—breast cancer	1.77e-05	9.93e-05	CcSEcCtD
Letrozole—Body temperature increased—Capecitabine—breast cancer	1.77e-05	9.93e-05	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—breast cancer	1.77e-05	9.92e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—CYP1B1—breast cancer	1.76e-05	0.000401	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	1.76e-05	0.0004	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDH1A1—breast cancer	1.76e-05	0.0004	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDH7A1—breast cancer	1.76e-05	0.0004	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX2—breast cancer	1.75e-05	0.000399	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTA2—breast cancer	1.75e-05	0.000399	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1B1—breast cancer	1.74e-05	0.000396	CbGpPWpGaD
Letrozole—Myalgia—Methotrexate—breast cancer	1.74e-05	9.76e-05	CcSEcCtD
Letrozole—Chest pain—Methotrexate—breast cancer	1.74e-05	9.76e-05	CcSEcCtD
Letrozole—Arthralgia—Methotrexate—breast cancer	1.74e-05	9.76e-05	CcSEcCtD
Letrozole—Tension—Doxorubicin—breast cancer	1.73e-05	9.74e-05	CcSEcCtD
Letrozole—Vomiting—Paclitaxel—breast cancer	1.73e-05	9.74e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—SULT1A1—breast cancer	1.73e-05	0.000394	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX4—breast cancer	1.73e-05	0.000394	CbGpPWpGaD
Letrozole—Dysgeusia—Doxorubicin—breast cancer	1.73e-05	9.72e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.73e-05	9.69e-05	CcSEcCtD
Letrozole—Malaise—Epirubicin—breast cancer	1.72e-05	9.67e-05	CcSEcCtD
Letrozole—Rash—Paclitaxel—breast cancer	1.72e-05	9.65e-05	CcSEcCtD
Letrozole—Dermatitis—Paclitaxel—breast cancer	1.72e-05	9.65e-05	CcSEcCtD
Letrozole—Discomfort—Methotrexate—breast cancer	1.72e-05	9.64e-05	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—breast cancer	1.72e-05	9.64e-05	CcSEcCtD
Letrozole—Vertigo—Epirubicin—breast cancer	1.72e-05	9.64e-05	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—breast cancer	1.71e-05	9.6e-05	CcSEcCtD
Letrozole—Back pain—Doxorubicin—breast cancer	1.71e-05	9.6e-05	CcSEcCtD
Letrozole—Headache—Paclitaxel—breast cancer	1.71e-05	9.59e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTA1—breast cancer	1.69e-05	0.000385	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—IDH1—breast cancer	1.69e-05	0.000385	CbGpPWpGaD
Letrozole—Palpitations—Epirubicin—breast cancer	1.69e-05	9.48e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PHGDH—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ADSL—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NME1—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—UMPS—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FHL2—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—NCOA1—breast cancer	1.68e-05	0.000383	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NAT2—breast cancer	1.67e-05	0.000381	CbGpPWpGaD
Letrozole—Cough—Epirubicin—breast cancer	1.67e-05	9.36e-05	CcSEcCtD
Letrozole—Anaphylactic shock—Methotrexate—breast cancer	1.67e-05	9.35e-05	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—breast cancer	1.67e-05	9.35e-05	CcSEcCtD
Letrozole—Asthenia—Docetaxel—breast cancer	1.66e-05	9.31e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—CYP19A1—breast cancer	1.66e-05	0.000377	CbGpPWpGaD
Letrozole—Infection—Methotrexate—breast cancer	1.65e-05	9.29e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HPSE—breast cancer	1.65e-05	0.000376	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—LDHB—breast cancer	1.65e-05	0.000376	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BRIP1—breast cancer	1.65e-05	0.000376	CbGpPWpGaD
Letrozole—Hypertension—Epirubicin—breast cancer	1.65e-05	9.26e-05	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—breast cancer	1.64e-05	9.21e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—CYP19A1—breast cancer	1.63e-05	0.000372	CbGpPWpGaD
Letrozole—Pruritus—Docetaxel—breast cancer	1.63e-05	9.18e-05	CcSEcCtD
Letrozole—Nervous system disorder—Methotrexate—breast cancer	1.63e-05	9.17e-05	CcSEcCtD
Letrozole—Chest pain—Epirubicin—breast cancer	1.63e-05	9.13e-05	CcSEcCtD
Letrozole—Myalgia—Epirubicin—breast cancer	1.63e-05	9.13e-05	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—breast cancer	1.63e-05	9.13e-05	CcSEcCtD
Letrozole—Anxiety—Epirubicin—breast cancer	1.62e-05	9.1e-05	CcSEcCtD
Letrozole—Nausea—Paclitaxel—breast cancer	1.62e-05	9.09e-05	CcSEcCtD
Letrozole—Skin disorder—Methotrexate—breast cancer	1.62e-05	9.09e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.61e-05	9.07e-05	CcSEcCtD
Letrozole—Hyperhidrosis—Methotrexate—breast cancer	1.61e-05	9.04e-05	CcSEcCtD
Letrozole—Discomfort—Epirubicin—breast cancer	1.61e-05	9.02e-05	CcSEcCtD
Letrozole—Asthenia—Capecitabine—breast cancer	1.6e-05	9.02e-05	CcSEcCtD
Letrozole—Malaise—Doxorubicin—breast cancer	1.59e-05	8.95e-05	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—breast cancer	1.59e-05	8.93e-05	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—breast cancer	1.59e-05	8.92e-05	CcSEcCtD
Letrozole—Anorexia—Methotrexate—breast cancer	1.59e-05	8.92e-05	CcSEcCtD
Letrozole—Pruritus—Capecitabine—breast cancer	1.58e-05	8.89e-05	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—breast cancer	1.58e-05	8.88e-05	CcSEcCtD
Letrozole—Diarrhoea—Docetaxel—breast cancer	1.58e-05	8.88e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—ABCC1—breast cancer	1.57e-05	0.000357	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMMR—breast cancer	1.57e-05	0.000357	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTA3—breast cancer	1.57e-05	0.000357	CbGpPWpGaD
Letrozole—Palpitations—Doxorubicin—breast cancer	1.56e-05	8.77e-05	CcSEcCtD
Letrozole—Oedema—Epirubicin—breast cancer	1.56e-05	8.75e-05	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—breast cancer	1.56e-05	8.75e-05	CcSEcCtD
Letrozole—Infection—Epirubicin—breast cancer	1.55e-05	8.7e-05	CcSEcCtD
Letrozole—Cough—Doxorubicin—breast cancer	1.54e-05	8.66e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—COMT—breast cancer	1.54e-05	0.000351	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—GSTP1—breast cancer	1.53e-05	0.000349	CbGpPWpGaD
Letrozole—Diarrhoea—Capecitabine—breast cancer	1.53e-05	8.6e-05	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—breast cancer	1.53e-05	8.58e-05	CcSEcCtD
Letrozole—Dizziness—Docetaxel—breast cancer	1.53e-05	8.58e-05	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—breast cancer	1.53e-05	8.57e-05	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—breast cancer	1.52e-05	8.54e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—COMT—breast cancer	1.52e-05	0.000346	CbGpPWpGaD
Letrozole—CYP19A1—Integrated Breast Cancer Pathway—AKT1—breast cancer	1.52e-05	0.000346	CbGpPWpGaD
Letrozole—Musculoskeletal discomfort—Methotrexate—breast cancer	1.52e-05	8.52e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—PPARGC1B—breast cancer	1.52e-05	0.000345	CbGpPWpGaD
Letrozole—Skin disorder—Epirubicin—breast cancer	1.51e-05	8.5e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—GSTP1—breast cancer	1.51e-05	0.000344	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—CAV1—breast cancer	1.51e-05	0.000344	CbGpPWpGaD
Letrozole—Hyperhidrosis—Epirubicin—breast cancer	1.51e-05	8.46e-05	CcSEcCtD
Letrozole—Insomnia—Methotrexate—breast cancer	1.51e-05	8.46e-05	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—breast cancer	1.5e-05	8.45e-05	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—breast cancer	1.5e-05	8.45e-05	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—breast cancer	1.5e-05	8.45e-05	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—breast cancer	1.5e-05	8.42e-05	CcSEcCtD
Letrozole—Paraesthesia—Methotrexate—breast cancer	1.5e-05	8.4e-05	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.49e-05	8.39e-05	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—breast cancer	1.49e-05	8.35e-05	CcSEcCtD
Letrozole—Anorexia—Epirubicin—breast cancer	1.49e-05	8.34e-05	CcSEcCtD
Letrozole—Dyspnoea—Methotrexate—breast cancer	1.48e-05	8.34e-05	CcSEcCtD
Letrozole—Somnolence—Methotrexate—breast cancer	1.48e-05	8.32e-05	CcSEcCtD
Letrozole—Dizziness—Capecitabine—breast cancer	1.48e-05	8.31e-05	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—breast cancer	1.47e-05	8.26e-05	CcSEcCtD
Letrozole—Vomiting—Docetaxel—breast cancer	1.47e-05	8.25e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—MED12—breast cancer	1.47e-05	0.000334	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—DPYD—breast cancer	1.47e-05	0.000334	CbGpPWpGaD
Letrozole—Dyspepsia—Methotrexate—breast cancer	1.47e-05	8.23e-05	CcSEcCtD
Letrozole—Rash—Docetaxel—breast cancer	1.46e-05	8.18e-05	CcSEcCtD
Letrozole—Dermatitis—Docetaxel—breast cancer	1.46e-05	8.18e-05	CcSEcCtD
Letrozole—Decreased appetite—Methotrexate—breast cancer	1.45e-05	8.13e-05	CcSEcCtD
Letrozole—Headache—Docetaxel—breast cancer	1.45e-05	8.13e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ALDOA—breast cancer	1.44e-05	0.000329	CbGpPWpGaD
Letrozole—Anaphylactic shock—Doxorubicin—breast cancer	1.44e-05	8.1e-05	CcSEcCtD
Letrozole—Oedema—Doxorubicin—breast cancer	1.44e-05	8.1e-05	CcSEcCtD
Letrozole—Gastrointestinal disorder—Methotrexate—breast cancer	1.44e-05	8.08e-05	CcSEcCtD
Letrozole—Fatigue—Methotrexate—breast cancer	1.44e-05	8.06e-05	CcSEcCtD
Letrozole—Infection—Doxorubicin—breast cancer	1.43e-05	8.05e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA4—breast cancer	1.43e-05	0.000326	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CA9—breast cancer	1.43e-05	0.000326	CbGpPWpGaD
Letrozole—Pain—Methotrexate—breast cancer	1.42e-05	8e-05	CcSEcCtD
Letrozole—Vomiting—Capecitabine—breast cancer	1.42e-05	7.99e-05	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—breast cancer	1.42e-05	7.98e-05	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—breast cancer	1.41e-05	7.94e-05	CcSEcCtD
Letrozole—Rash—Capecitabine—breast cancer	1.41e-05	7.92e-05	CcSEcCtD
Letrozole—Insomnia—Epirubicin—breast cancer	1.41e-05	7.92e-05	CcSEcCtD
Letrozole—CYP3A4—Biological oxidations—GSTM1—breast cancer	1.41e-05	0.000321	CbGpPWpGaD
Letrozole—Dermatitis—Capecitabine—breast cancer	1.41e-05	7.92e-05	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—breast cancer	1.41e-05	7.91e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—NCOA3—breast cancer	1.4e-05	0.000319	CbGpPWpGaD
Letrozole—Headache—Capecitabine—breast cancer	1.4e-05	7.87e-05	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—breast cancer	1.4e-05	7.87e-05	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—breast cancer	1.4e-05	7.86e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA2—breast cancer	1.4e-05	0.000318	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX2—breast cancer	1.4e-05	0.000318	CbGpPWpGaD
Letrozole—Hyperhidrosis—Doxorubicin—breast cancer	1.39e-05	7.83e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—SLC2A2—breast cancer	1.39e-05	0.000317	CbGpPWpGaD
Letrozole—CYP3A4—Metapathway biotransformation—GSTM1—breast cancer	1.39e-05	0.000317	CbGpPWpGaD
Letrozole—Dyspnoea—Epirubicin—breast cancer	1.39e-05	7.8e-05	CcSEcCtD
Letrozole—Somnolence—Epirubicin—breast cancer	1.39e-05	7.78e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—SULT1A1—breast cancer	1.38e-05	0.000314	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX4—breast cancer	1.38e-05	0.000314	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	1.38e-05	0.000314	CbGpPWpGaD
Letrozole—Anorexia—Doxorubicin—breast cancer	1.37e-05	7.72e-05	CcSEcCtD
Letrozole—Nausea—Docetaxel—breast cancer	1.37e-05	7.71e-05	CcSEcCtD
Letrozole—Feeling abnormal—Methotrexate—breast cancer	1.37e-05	7.71e-05	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—breast cancer	1.37e-05	7.71e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CPT1A—breast cancer	1.36e-05	0.00031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ABCG2—breast cancer	1.36e-05	0.00031	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTR—breast cancer	1.36e-05	0.00031	CbGpPWpGaD
Letrozole—Gastrointestinal pain—Methotrexate—breast cancer	1.36e-05	7.65e-05	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—breast cancer	1.35e-05	7.61e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—GSTA1—breast cancer	1.35e-05	0.000307	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—IDH1—breast cancer	1.35e-05	0.000307	CbGpPWpGaD
Letrozole—Gastrointestinal disorder—Epirubicin—breast cancer	1.35e-05	7.56e-05	CcSEcCtD
Letrozole—Fatigue—Epirubicin—breast cancer	1.34e-05	7.55e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—HPGDS—breast cancer	1.34e-05	0.000304	CbGpPWpGaD
Letrozole—CYP3A4—Biological oxidations—CYP1A1—breast cancer	1.34e-05	0.000304	CbGpPWpGaD
Letrozole—Pain—Epirubicin—breast cancer	1.33e-05	7.49e-05	CcSEcCtD
Letrozole—Constipation—Epirubicin—breast cancer	1.33e-05	7.49e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—NAT2—breast cancer	1.33e-05	0.000303	CbGpPWpGaD
Letrozole—Nausea—Capecitabine—breast cancer	1.33e-05	7.46e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—HBA1—breast cancer	1.33e-05	0.000303	CbGpPWpGaD
Letrozole—Urticaria—Methotrexate—breast cancer	1.32e-05	7.43e-05	CcSEcCtD
Letrozole—CYP3A4—Metapathway biotransformation—CYP1A1—breast cancer	1.32e-05	0.0003	CbGpPWpGaD
Letrozole—Abdominal pain—Methotrexate—breast cancer	1.32e-05	7.39e-05	CcSEcCtD
Letrozole—Body temperature increased—Methotrexate—breast cancer	1.32e-05	7.39e-05	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.31e-05	7.38e-05	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—breast cancer	1.3e-05	7.33e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—GSTT1—breast cancer	1.3e-05	0.000295	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ACHE—breast cancer	1.3e-05	0.000295	CbGpPWpGaD
Letrozole—Paraesthesia—Doxorubicin—breast cancer	1.29e-05	7.27e-05	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—breast cancer	1.29e-05	7.22e-05	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—breast cancer	1.28e-05	7.21e-05	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—breast cancer	1.28e-05	7.2e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—breast cancer	1.27e-05	7.16e-05	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—breast cancer	1.27e-05	7.13e-05	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—breast cancer	1.25e-05	7.04e-05	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—breast cancer	1.24e-05	6.99e-05	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—breast cancer	1.24e-05	6.98e-05	CcSEcCtD
Letrozole—Urticaria—Epirubicin—breast cancer	1.24e-05	6.95e-05	CcSEcCtD
Letrozole—Pain—Doxorubicin—breast cancer	1.23e-05	6.93e-05	CcSEcCtD
Letrozole—Constipation—Doxorubicin—breast cancer	1.23e-05	6.93e-05	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—breast cancer	1.23e-05	6.92e-05	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—breast cancer	1.23e-05	6.92e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYP17A1—breast cancer	1.23e-05	0.00028	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ENO1—breast cancer	1.22e-05	0.000277	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS1—breast cancer	1.22e-05	0.000277	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	1.21e-05	0.000276	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—ALB—breast cancer	1.2e-05	0.000272	CbGpPWpGaD
Letrozole—Asthenia—Methotrexate—breast cancer	1.19e-05	6.71e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYP2D6—breast cancer	1.19e-05	0.000271	CbGpPWpGaD
Letrozole—Feeling abnormal—Doxorubicin—breast cancer	1.19e-05	6.67e-05	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—breast cancer	1.18e-05	6.62e-05	CcSEcCtD
Letrozole—Pruritus—Methotrexate—breast cancer	1.18e-05	6.62e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—NCOA2—breast cancer	1.17e-05	0.000266	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MED12—breast cancer	1.17e-05	0.000266	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—DPYD—breast cancer	1.17e-05	0.000266	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALDOA—breast cancer	1.15e-05	0.000262	CbGpPWpGaD
Letrozole—Urticaria—Doxorubicin—breast cancer	1.15e-05	6.43e-05	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—breast cancer	1.14e-05	6.4e-05	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—breast cancer	1.14e-05	6.4e-05	CcSEcCtD
Letrozole—Diarrhoea—Methotrexate—breast cancer	1.14e-05	6.4e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—FASN—breast cancer	1.13e-05	0.000258	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—BCHE—breast cancer	1.13e-05	0.000257	CbGpPWpGaD
Letrozole—Asthenia—Epirubicin—breast cancer	1.12e-05	6.28e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—SLC5A5—breast cancer	1.12e-05	0.000254	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA3—breast cancer	1.12e-05	0.000254	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A2—breast cancer	1.11e-05	0.000252	CbGpPWpGaD
Letrozole—Pruritus—Epirubicin—breast cancer	1.1e-05	6.19e-05	CcSEcCtD
Letrozole—Dizziness—Methotrexate—breast cancer	1.1e-05	6.19e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—MTR—breast cancer	1.09e-05	0.000247	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CPT1A—breast cancer	1.09e-05	0.000247	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCG2—breast cancer	1.09e-05	0.000247	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—SLC2A1—breast cancer	1.08e-05	0.000245	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NQO1—breast cancer	1.08e-05	0.000245	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SYNJ2—breast cancer	1.07e-05	0.000245	CbGpPWpGaD
Letrozole—Diarrhoea—Epirubicin—breast cancer	1.07e-05	5.99e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HPGDS—breast cancer	1.06e-05	0.000242	CbGpPWpGaD
Letrozole—Vomiting—Methotrexate—breast cancer	1.06e-05	5.95e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—HBA1—breast cancer	1.06e-05	0.000241	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	1.06e-05	0.00024	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP3A4—breast cancer	1.05e-05	0.000239	CbGpPWpGaD
Letrozole—Rash—Methotrexate—breast cancer	1.05e-05	5.9e-05	CcSEcCtD
Letrozole—Dermatitis—Methotrexate—breast cancer	1.05e-05	5.89e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	1.05e-05	0.000238	CbGpPWpGaD
Letrozole—Headache—Methotrexate—breast cancer	1.04e-05	5.86e-05	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—breast cancer	1.03e-05	5.81e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—CYP1B1—breast cancer	1.03e-05	0.000235	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTT1—breast cancer	1.03e-05	0.000235	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ACHE—breast cancer	1.03e-05	0.000235	CbGpPWpGaD
Letrozole—Dizziness—Epirubicin—breast cancer	1.03e-05	5.79e-05	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—breast cancer	1.02e-05	5.73e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—HSP90AA1—breast cancer	1.01e-05	0.000231	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NDUFS3—breast cancer	9.99e-06	0.000228	CbGpPWpGaD
Letrozole—Vomiting—Epirubicin—breast cancer	9.91e-06	5.57e-05	CcSEcCtD
Letrozole—Nausea—Methotrexate—breast cancer	9.89e-06	5.56e-05	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—breast cancer	9.87e-06	5.54e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—NCOA1—breast cancer	9.86e-06	0.000224	CbGpPWpGaD
Letrozole—Rash—Epirubicin—breast cancer	9.83e-06	5.52e-05	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—breast cancer	9.82e-06	5.51e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CYP17A1—breast cancer	9.77e-06	0.000222	CbGpPWpGaD
Letrozole—Headache—Epirubicin—breast cancer	9.76e-06	5.48e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—STK11—breast cancer	9.71e-06	0.000221	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ENO1—breast cancer	9.67e-06	0.00022	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS1—breast cancer	9.67e-06	0.00022	CbGpPWpGaD
Letrozole—Dizziness—Doxorubicin—breast cancer	9.53e-06	5.36e-05	CcSEcCtD
Letrozole—CYP2A6—Metabolism—CYP2D6—breast cancer	9.48e-06	0.000216	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CHST9—breast cancer	9.4e-06	0.000214	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA2—breast cancer	9.31e-06	0.000212	CbGpPWpGaD
Letrozole—Nausea—Epirubicin—breast cancer	9.26e-06	5.2e-05	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—breast cancer	9.17e-06	5.15e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PTEN—breast cancer	9.12e-06	0.000208	CbGpPWpGaD
Letrozole—Rash—Doxorubicin—breast cancer	9.09e-06	5.11e-05	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—breast cancer	9.08e-06	5.1e-05	CcSEcCtD
Letrozole—Headache—Doxorubicin—breast cancer	9.03e-06	5.07e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—COMT—breast cancer	9.03e-06	0.000206	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—FASN—breast cancer	9.03e-06	0.000206	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—BCHE—breast cancer	8.99e-06	0.000205	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTP1—breast cancer	8.99e-06	0.000205	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COX11—breast cancer	8.91e-06	0.000203	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC5A5—breast cancer	8.88e-06	0.000202	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—HMOX1—breast cancer	8.86e-06	0.000202	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ITPR1—breast cancer	8.84e-06	0.000201	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NQO1—breast cancer	8.58e-06	0.000195	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—SLC2A1—breast cancer	8.58e-06	0.000195	CbGpPWpGaD
Letrozole—Nausea—Doxorubicin—breast cancer	8.56e-06	4.81e-05	CcSEcCtD
Letrozole—CYP19A1—Metabolism—ABCB1—breast cancer	8.51e-06	0.000194	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP3A4—breast cancer	8.36e-06	0.00019	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—TYMS—breast cancer	8.36e-06	0.00019	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NCOR1—breast cancer	8.26e-06	0.000188	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GSTM1—breast cancer	8.26e-06	0.000188	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PLA2G4A—breast cancer	8.26e-06	0.000188	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1B1—breast cancer	8.22e-06	0.000187	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SHMT1—breast cancer	8.15e-06	0.000186	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CDA—breast cancer	8.15e-06	0.000186	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HSP90AA1—breast cancer	8.06e-06	0.000184	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—GPX1—breast cancer	7.91e-06	0.00018	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOA1—breast cancer	7.84e-06	0.000179	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A5—breast cancer	7.84e-06	0.000179	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLCO1B1—breast cancer	7.84e-06	0.000179	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CYP1A1—breast cancer	7.83e-06	0.000178	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ERCC2—breast cancer	7.77e-06	0.000177	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—STK11—breast cancer	7.73e-06	0.000176	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP19A1—breast cancer	7.73e-06	0.000176	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—APRT—breast cancer	7.57e-06	0.000172	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—MTHFR—breast cancer	7.3e-06	0.000166	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—COMT—breast cancer	7.19e-06	0.000164	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTP1—breast cancer	7.15e-06	0.000163	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ESRRA—breast cancer	7.12e-06	0.000162	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ANGPTL4—breast cancer	7.12e-06	0.000162	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—HMOX1—breast cancer	7.06e-06	0.000161	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ITPR1—breast cancer	7.04e-06	0.00016	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ABCB1—breast cancer	6.77e-06	0.000154	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HADHB—breast cancer	6.75e-06	0.000154	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPI—breast cancer	6.75e-06	0.000154	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—CAV1—breast cancer	6.73e-06	0.000153	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—TYMS—breast cancer	6.65e-06	0.000151	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PLA2G4A—breast cancer	6.57e-06	0.00015	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GSTM1—breast cancer	6.57e-06	0.00015	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NCOR1—breast cancer	6.57e-06	0.00015	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDH7A1—breast cancer	6.44e-06	0.000147	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDH1A1—breast cancer	6.44e-06	0.000147	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	6.43e-06	0.000146	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—GPX1—breast cancer	6.3e-06	0.000143	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CYP1A1—breast cancer	6.23e-06	0.000142	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ERCC2—breast cancer	6.18e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FHL2—breast cancer	6.17e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NME1—breast cancer	6.17e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—UMPS—breast cancer	6.17e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ADSL—breast cancer	6.17e-06	0.000141	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PHGDH—breast cancer	6.17e-06	0.000141	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CG—breast cancer	6.13e-06	0.00014	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—LDHB—breast cancer	6.05e-06	0.000138	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BRIP1—breast cancer	6.05e-06	0.000138	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPSE—breast cancer	6.05e-06	0.000138	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—MTHFR—breast cancer	5.81e-06	0.000132	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA3—breast cancer	5.74e-06	0.000131	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMMR—breast cancer	5.74e-06	0.000131	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCC1—breast cancer	5.74e-06	0.000131	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PPARGC1B—breast cancer	5.56e-06	0.000127	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CD—breast cancer	5.39e-06	0.000123	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—CAV1—breast cancer	5.36e-06	0.000122	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—ALB—breast cancer	5.32e-06	0.000121	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA4—breast cancer	5.25e-06	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CA9—breast cancer	5.25e-06	0.00012	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX2—breast cancer	5.12e-06	0.000116	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA2—breast cancer	5.12e-06	0.000116	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—NOS3—breast cancer	5.09e-06	0.000116	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX4—breast cancer	5.05e-06	0.000115	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SULT1A1—breast cancer	5.05e-06	0.000115	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—IDH1—breast cancer	4.94e-06	0.000112	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTA1—breast cancer	4.94e-06	0.000112	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CG—breast cancer	4.88e-06	0.000111	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NAT2—breast cancer	4.88e-06	0.000111	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CB—breast cancer	4.7e-06	0.000107	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTGS2—breast cancer	4.66e-06	0.000106	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CD—breast cancer	4.29e-06	9.77e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MED12—breast cancer	4.28e-06	9.75e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—DPYD—breast cancer	4.28e-06	9.75e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—ALB—breast cancer	4.24e-06	9.65e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALDOA—breast cancer	4.21e-06	9.59e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA3—breast cancer	4.09e-06	9.31e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A2—breast cancer	4.06e-06	9.25e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PTEN—breast cancer	4.06e-06	9.25e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—NOS3—breast cancer	4.05e-06	9.23e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CPT1A—breast cancer	3.98e-06	9.06e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTR—breast cancer	3.98e-06	9.06e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCG2—breast cancer	3.98e-06	9.06e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HPGDS—breast cancer	3.9e-06	8.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HBA1—breast cancer	3.88e-06	8.83e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ACHE—breast cancer	3.78e-06	8.62e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTT1—breast cancer	3.78e-06	8.62e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CB—breast cancer	3.74e-06	8.52e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTGS2—breast cancer	3.71e-06	8.44e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP17A1—breast cancer	3.58e-06	8.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS1—breast cancer	3.55e-06	8.08e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ENO1—breast cancer	3.55e-06	8.08e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP2D6—breast cancer	3.48e-06	7.92e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA2—breast cancer	3.41e-06	7.77e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—FASN—breast cancer	3.31e-06	7.54e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—BCHE—breast cancer	3.3e-06	7.51e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC5A5—breast cancer	3.26e-06	7.42e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PTEN—breast cancer	3.23e-06	7.36e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—SLC2A1—breast cancer	3.14e-06	7.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NQO1—breast cancer	3.14e-06	7.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1B1—breast cancer	3.01e-06	6.87e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HSP90AA1—breast cancer	2.96e-06	6.73e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOA1—breast cancer	2.88e-06	6.55e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—PIK3CA—breast cancer	2.86e-06	6.52e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—STK11—breast cancer	2.83e-06	6.46e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP19A1—breast cancer	2.83e-06	6.46e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—COMT—breast cancer	2.64e-06	6e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTP1—breast cancer	2.62e-06	5.97e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—HMOX1—breast cancer	2.59e-06	5.89e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ITPR1—breast cancer	2.58e-06	5.88e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ABCB1—breast cancer	2.48e-06	5.65e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—TYMS—breast cancer	2.44e-06	5.55e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NCOR1—breast cancer	2.41e-06	5.49e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GSTM1—breast cancer	2.41e-06	5.49e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PLA2G4A—breast cancer	2.41e-06	5.49e-05	CbGpPWpGaD
Letrozole—CYP19A1—Metabolism—AKT1—breast cancer	2.34e-06	5.33e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—GPX1—breast cancer	2.31e-06	5.26e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CYP1A1—breast cancer	2.28e-06	5.2e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—PIK3CA—breast cancer	2.28e-06	5.19e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ERCC2—breast cancer	2.27e-06	5.16e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—MTHFR—breast cancer	2.13e-06	4.85e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—CAV1—breast cancer	1.96e-06	4.47e-05	CbGpPWpGaD
Letrozole—CYP2A6—Metabolism—AKT1—breast cancer	1.86e-06	4.24e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CG—breast cancer	1.79e-06	4.08e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CD—breast cancer	1.57e-06	3.58e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—ALB—breast cancer	1.55e-06	3.54e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—NOS3—breast cancer	1.49e-06	3.38e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CB—breast cancer	1.37e-06	3.12e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTGS2—breast cancer	1.36e-06	3.09e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PTEN—breast cancer	1.19e-06	2.7e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—PIK3CA—breast cancer	8.36e-07	1.9e-05	CbGpPWpGaD
Letrozole—CYP3A4—Metabolism—AKT1—breast cancer	6.83e-07	1.56e-05	CbGpPWpGaD
